


We assess the performance of Milliman Advance Risk Adjusters (MARA) versus other common methods for predicting high-cost members in U.S. commercial health plans.
Models for commercial, Medicaid and Medicare populations.
With the addition of Rising Risk in MARA, customers are able to more accurately identify and differentiate low-cost individuals who are expected to incur significantly higher costs in the next year, and individuals that are expected to decrease in costs in the next year.
With the addition of Rising Risk in MARA, customers are able to more accurately identify and differentiate low-cost individuals who are expected to incur significantly higher costs in the next year, and individuals that are expected to decrease in costs in the next year.